Figure 2 - uploaded by Thiago Rezende
Content may be subject to copyright.
Cortical atrophy in AD patients (FDR corrected for multiple comparisons). 

Cortical atrophy in AD patients (FDR corrected for multiple comparisons). 

Source publication
Article
Full-text available
Objectives To compare cortical atrophy’s patterns between AD patients and healthy controls; to verify correlations between neuropsychiatric syndromes and cortical atrophy. Method 33 AD patients were examined by Neuropsychiatric Inventory (NPI). Patients and 29 controls underwent a 3T MRI scanning. We considered four NPI syndromes: affective, apath...

Context in source publication

Context 1
... and night time behavior disorders, and appetite and eating disor ders. Questions were read to the caregiver exactly as written. If the caregiver did not understand the question, it was re peated with synonyms. After reading the question, the care giver was asked if he/she noticed the behavior of the patient. If the answer was negative, the next set of questions was asked. If the answer was positive, subquestions were read and possible answers were “yes” or “no” The caregiver was then instructed to state the frequency and severity of the be havior in that domain, regarding alterations revealed by the subquestions. Scores were calculated by multiplying the fre quency (1–4: rarely, sometimes, often, and very often) and the severity (1–3: mild, moderate, and severe). Based on a study by Aalten et al. 1 , we considered the following four subsyn dromes: apathy, hyperactivity (the sum of agitation, disin hibition, irritability, euphoria, and aberrant motor behavior scores), psychosis (delusions, hallucinations, and night-time behavior disturbances), and affective syndrome (depression and anxiety). CDR was based on a semi-structured interview and the classification was based on the guidelines. The data were obtained by a 3T MRI scanner (Philips Achieva, Best, Netherlands). A set of structural images was composed of the following sequences: a) sagittal high-resolution T1-weighted with gradient echo images that were acquired with TR/TE = 7/3.2 ms, field of view (FOV) = 240×240, and isotropic voxels of 1 mm 3 , b) coronal and axial Fluid-attenuated Inversion Recovery, T2-weighted imag es, anatomically aligned at the hippocampus with image pa rameters set to TR/TE/TI = 12000/140/2850, FOV = 220×206, voxels reconstructed to 0.45×0.45×4.00 mm 3 , and gap between slices set to 1 mm, c) coronal inversion recovery T1-weighted images with TR/TE/TI = 3550/15/400, FOV = 180×180, and voxels reconstructed to 0.42×0.42×3.00 mm 3 , and d) coronal multi-echo (5 echoes) T2-weighted images with TR/TE = 3300/30, FOV = 180×180, voxels reconstructed to 0.42×0.42×3.00 mm 3 . Cortical thickness was determined using FreeSurfer soft ware v.5.3. Measurements were performed according to the protocol suggested by Fischl and Dale 7 . First, the images were aligned to the Talairach and Tournoux atlas. Next, the im ages grayscale intensity was normalized and corrected for magnetic field inhomogeneity. The extra-cerebral voxels were removed by the skull-stripped protocol. Next, the voxels were labeled as GM, WM, or cerebral spinal fluid and two surfaces were created: pial and white 7,8 . Cortical thickness was calculat ed as the shortest distance between the pial and white surface at each vertex across the cortical mantle. For all analyses, a Gaussian filter with 10 mm full width at half maximum was used for smoothing the surface. To evaluate possible cortical thickness differences, we used a General Linear Model with age as regressor. In order to correct for multiple comparisons, a False Discovery Rate test (FDR) was applied over the t-score maps generated from group analysis, enabling the identifica tion of significant clusters. To assess possible correlations be tween NPS and cortical thickness of patients, we performed a Pearson correlation. All correlation analyses were corrected for multiple comparisons using FDR test. All procedures were in accordance with the ethi- cal standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2000. Informed consent was obtained from all patients. Demographic and cognitive results are shown in Table 1. The distributions of NPI scores for each neuropsychiatric syn drome are shown in Figure 1. We performed the analysis considering groups CDR 1 and CDR 2 as one group, since we hypothesized that both groups could represent a continuum regarding AD’s course: the more atrophy due to neurodegeneration, the more prominent are the neuropsychiatric symptoms. In fact, in our sample, CDR 2 group had much more neuropsychiatric symptoms (Total NPI score mean ± SD: 18.0 ± 13.49) than CDR 1 group (8.43 ± 4.37), p = 0.03. We found significant differences between cortical thick ness measures in AD patients compared with the normal elderly, as shown by cortical atrophy in the AD group in the temporal lobe areas, the bilateral entorhinal cortex, the left middle and left inferior temporal gyrus, the posterior regions of right superior temporal sulcus, the bilateral precuneus, the bilateral superior frontal gyrus, and the bilateral lateral orbitofrontal gyri. We also found significant differences in the bilateral insula, the isthmus of cingulate gyrus , the bilateral anterior cingulate cortex, the left posterior cingulate cortex, the bilateral supramarginal gyri, the right fusiform gyrus, the inferior parietal gyrus, and the superior parietal gyrus in both hemispheres. All results were FDR-corrected for multiple comparisons (Figure 2 and Tables 2 and 3). We found significant correlations between cortical thickness and affective syndrome (depression and anxiety) (Figure 3 and Table 4). All the other regressions (apathy, psy chosis, and hyperactivity) did not survive multiple compari son corrections. The significant differences found in the cortical thickness of the AD group and the normal elderly corresponds to the well-established cortical atrophy of AD patients, even in mild and moderate stages. According to the pattern of AD atrophy, earlier atrophic sites are related to temporal and pari etal lobes. As the degeneration progresses, areas of the fron tal lobe may be affected. One important issue is the overlapping of cognitive symp toms from depression or early dementia. This overlapping sometimes makes it difficult to distinguish affective syn drome and dementia. Depression may predict a faster cognitive deterioration; depressed patients with MCI have twice the risk of progressing to AD compared with non-de pressed patients. In this study, we found significant correlations between cortical structures in the right hemisphere and affective syn drome. Interestingly, some of the more correlated regions (in sula, lateral orbitofrontal, and temporal pole) are important parts of brain networks that process emotional information. Although insular functions are not fully understood, there is evidence that the insula, especially its anterior part, pro cesses emotional experiences. Based on the role of the in sula encoding interoceptive signals from the body’s internal milieu that reflect autonomic activity, Damasio argued that the insula is the location within the brain where subjective feelings of emotion are generated 9 . The anterior insula is also a key region of the SN, which is involved in detecting, inte grating, and filtering relevant interoceptive, autonomic, and emotional information. The SN, with the anterior insula as its integral outflow hub, assists target brain regions to generate behavioral responses to salient stimuli 10 . In a previous study of our group, we showed that connectivity in the right insula of AD patients was related to symptoms of agitation, disin hibition, irritability, euphoria, and aberrant motor behavior 4 . Moreover, task-based functional MRI studies showed that hy peractivity of anterior insula has been consistently implicated with anxiety disorders 11 . Takahashi et al. also found GM vol ume reductions in the left anterior insula in depression 12 . We also found a significant correlation between affec tive syndrome and the orbitofrontal cortex (a region involved with socioemotional processing) and the right temporal pole. Although temporal pole atrophy is more commonly seen in a temporal variant of frontotemporal dementia than in AD, dysfunctions in the right side of this region are associated with changes in personality and social behavior. Moreover, other affect-related problems in temporal pole atrophy include depression, irritability, apathy, and emotion al blunting. Increased associations between the left temporal lobe and depressive and anxiety symptoms are recurrent in the literature, despite the existence of controversies concern ing laterality. Mendez et al., for example, verified a correla tion between anxiety and dysthymia with hypoperfusion of the right temporal lobe 13 . Other studies have also examined the correlation between depression and a reduction in cortical thickness on the entorhinal cortex and the anterior cingu lated cortex 14 . Because of these findings, it is possible to note the relevance of correlations between affective syndrome and the frontal and temporal lobes. The most likely hypothesis to explain the pathophysiology of affective syndrome is based on the proposition that disturbances in the temporal and frontal lobes may influence brain network disruptions, which occurs, for instance, in the limbic system. These disruptions may disorganize serotonergic and dopaminergic neurotrans- mitters in frontal-subcortical pathways and impact behavior. Thus, depressive symptoms in MCI and AD patients become clinically relevant and reflect dysfunctions in the frontal lobe with associated behavioral manifestations – agitation, disin hibition, and restlessness 15 . Our findings of a correlation between affective syndrome and frontal atrophy are also supported by information from the literature. A post-mortem study demonstrated a reduction in the density of prefrontal cortical glial cells, as well as providing convincing evidence for diminished prefrontal neuronal size in patients with depression 16, 17 . A recent meta- analysis involving MRI studies in late-life depression reported significant volume reductions in the orbitofrontal cortex, putamen, and thalamus 18 . The authors hypothesized that dis ruption of networks linking these frontal-subcortical struc tures, as well as limbic networks, exert an important role in the pathophysiology of late-life depression. ...

Citations

... Neuropsychiatric symptoms are described in patients with Alzheimer's disease, and animal models have suggested that behavioural and psychological symptoms increase with progressive neuropathology [4]. Depression and anxiety, as noted in our patient, have been suggested to correlate with atrophy of frontal, temporal, and insular areas [5], although in our patient, no signifcant cerebral atrophy could be detected. Te contribution of neuropsychiatric symptoms to cognitive decline has also been studied by some. ...
Article
Full-text available
Alzheimer’s disease (AD) is classified as a tauopathy and is the most common neuropathological correlate of dementia/cognitive impairment. AD is neuropathologically characterized by the presence of beta-amyloid immunoreactive senile plaques and tau positive neurofibrillary tangles. Neuropsychiatric symptoms of AD however continue to be underscored, and therefore, neuropathological correlates of these neuropsychiatric symptoms are not readily studied. Presented here is a case of 60-year-old female who initially presented with anxiety and depression, and continued to be the predominant symptoms although mild cognitive impairment was noted as per the available clinical notes. Postmortem examination of the brain revealed severe Alzheimer’s type neuropathological changes, which included significant tau and beta-amyloid pathology in limbic regions, which were thought to represent correlates of the patient’s depression and anxiety. This case report illustrates the possible neuropathological correlates of neuropsychiatric symptoms in patients with AD. The author hopes that such a case will promote more in-depth studies into the pathophysiology of neuropsychiatric manifestations in AD.
... Moreover, the frequency of NPS varies across the various neurodegenerative and cerebrovascular disease. Affective symptoms like anxiety and depression are more prevalent in Alzheimer's disease (AD) and vascular dementia (VaD) [4][5][6][7]. Apathy is most commonly reported in AD and frontotemporal dementia (FTD), and associated with functional impairment and disease progression [8,9]. But the pattern of apathy presentation differs such that AD-related apathy is indicative of depression, cognitive dysfunction, and conversion from amnestic mild cognitive impairment (aMCI) to AD [10,11], whilst FTD-related apathy is associated with measures of social cognition and executive dysfunction [11][12][13]. ...
... Since the manifestation of NPS likely represents brain abnormalities and may reflect progression of disease, it is important to recognise the neural basis of NPS in neurodegenerative and cerebrovascular diseases. Regional brain changes have been implicated in NPS in neurodegenerative and cerebrovascular diseases [5,12,15,[18][19][20][21][22][23]. Symptoms of apathy, anxiety, and depression reported in aMCI have been linked to smaller cortical thickness and volume in the frontal, temporal, and parietal regions [5,19,21]. ...
... Regional brain changes have been implicated in NPS in neurodegenerative and cerebrovascular diseases [5,12,15,[18][19][20][21][22][23]. Symptoms of apathy, anxiety, and depression reported in aMCI have been linked to smaller cortical thickness and volume in the frontal, temporal, and parietal regions [5,19,21]. In PD, lower frontal lobe volume was related to affective, psychotic, and apathy symptoms [22], whilst a smaller cortical thickness and volume of the frontotemporal, insular, and limbic regions was related to apathy and disinhibition in FTD and ALS [12,15,23]. ...
Article
Background: Neuropsychiatric symptoms (NPS) are a core feature of most neurodegenerative and cerebrovascular diseases. White matter hyperintensities and brain atrophy have been implicated in NPS. We aimed to investigate the relative contribution of white matter hyperintensities and cortical thickness to NPS in participants across neurodegenerative and cerebrovascular diseases. Methods: Five hundred thirteen participants with one of these conditions, i.e. Alzheimer's Disease/Mild Cognitive Impairment, Amyotrophic Lateral Sclerosis, Frontotemporal Dementia, Parkinson's Disease, or Cerebrovascular Disease, were included in the study. NPS were assessed using the Neuropsychiatric Inventory - Questionnaire and grouped into hyperactivity, psychotic, affective, and apathy subsyndromes. White matter hyperintensities were quantified using a semi-automatic segmentation technique and FreeSurfer cortical thickness was used to measure regional grey matter loss. Results: Although NPS were frequent across the five disease groups, participants with frontotemporal dementia had the highest frequency of hyperactivity, apathy, and affective subsyndromes compared to other groups, whilst psychotic subsyndrome was high in both frontotemporal dementia and Parkinson's disease. Results from univariate and multivariate results showed that various predictors were associated with neuropsychiatric subsyndromes, especially cortical thickness in the inferior frontal, cingulate, and insula regions, sex(female), global cognition, and basal ganglia-thalamus white matter hyperintensities. Conclusions: In participants with neurodegenerative and cerebrovascular diseases, our results suggest that smaller cortical thickness and white matter hyperintensity burden in several cortical-subcortical structures may contribute to the development of NPS. Further studies investigating the mechanisms that determine the progression of NPS in various neurodegenerative and cerebrovascular diseases are needed.
... Patients with anxiety and those with depression showed different levels of activation and inhibition of brain activity in different brain regions. Hayata et al. (33) studied the difference in cerebral hemispheric activity in anxiety and depression using different brain activity pattern models of distinct regions. Bruder et al. (34) also came to a similar conclusion. ...
Article
Full-text available
Background Due to substantial comorbidities of major depressive disorder (MDD) and anxiety disorder (AN), these two disorders must be distinguished. Accurate identification and diagnosis facilitate effective and prompt treatment. EEG biomarkers are a potential research hotspot for neuropsychiatric diseases. The purpose of this study was to investigate the differences in EEG power spectrum at theta oscillations between patients with MDD and patients with AN. Methods Spectral analysis was used to study 66 patients with MDD and 43 patients with AN. Participants wore 16-lead EEG caps to measure resting EEG signals. The EEG power spectrum was measured using the fast Fourier transform. Independent samples t-test was used to analyze the EEG power values of the two groups, and p < 0.05 was statistically significant. Results EEG power spectrum of the MDD group significantly differed from the AN group in the theta oscillation on 4–7 Hz at eight electrode points at F3, O2, T3, P3, P4, FP1, FP2, and F8. Conclusion Participants with anxiety demonstrated reduced power in the prefrontal cortex, left temporal lobe, and right occipital regions. Confirmed by further studies, theta oscillations could be another biomarker that distinguishes MDD from AN.
... In patients with AD dementia, one previous study found that patients with persistent neuropsychiatric symptoms had worse cognitive outcomes (Poulin et al., 2017). Regarding neuroimaging biomarkers, some studies found that depressive and anxiety symptoms were associated with more AD neuroimaging hallmarks in either Mild Cognitive Impairment (MCI) or AD patients (Chen et al., 2021;Mendez, 2021), such as lower gray matter volume (GM) (Son et al., 2013;Dhikav et al., 2014;Fujishima et al., 2014;Lebedeva et al., 2014;Tagai et al., 2014;Hayata et al., 2015;Wu et al., 2020), lower glucose metabolism and/or perfusion (Hashimoto et al., 2006;Levy-Cooperman et al., 2008), and higher amyloid deposition (Brendel et al., 2015;Bensamoun et al., 2016;Krell-Roesch et al., 2019). However, conflicting results have been reported in other studies showing a link between depressive symptoms and higher gray matter volume (Auning et al., 2015;Enache et al., 2015), glucose metabolism and/or perfusion (Tagai et al., 2014;Auning et al., 2015;Brendel et al., 2015;Tommaso et al., 2016) or no association between psychoaffective factors and neuroimaging markers (Horínek et al., 2006;Starkstein et al., 2009;Serra et al., 2010;Poulin et al., 2011;Mori et al., 2014;Chung et al., 2015;Bensamoun et al., 2016;Huey et al., 2017;Banning et al., 2019). ...
... This is in line with a previous study showing a higher frequency of depressive symptoms in clinical MCI and AD patients compared to controls, while anxiety symptoms were only different between mild and severe AD (Fernández-Martínez et al., 2010). Additionally, we found no association of anxiety symptoms with cognition and neuroimaging data, which is at odds with previous studies showing significant relationships with GM atrophy (Tagai et al., 2014;Hayata et al., 2015) and glucose hypometabolism (Hashimoto et al., 2006) in AD. This might be due to the fact that, in the present study, we focused on state measures of either anxiety or depressive symptoms, while these previous studies assessed trait anxiety. ...
Article
Full-text available
Background Depressive and anxiety symptoms are frequent in Alzheimer’s disease and associated with increased risk of developing Alzheimer’s disease in older adults. We sought to examine their relationships to Alzheimer’s disease biomarkers across the preclinical and clinical stages of the disease. Method Fifty-six healthy controls, 35 patients with subjective cognitive decline and 56 amyloid-positive cognitively impaired patients on the Alzheimer’s continuum completed depression and anxiety questionnaires, neuropsychological tests and neuroimaging assessments. We performed multiple regressions in each group separately to assess within group associations of depressive and anxiety symptoms with either cognition (global cognition and episodic memory) or neuroimaging data (gray matter volume, glucose metabolism and amyloid load). Results Depressive symptoms, but not anxiety, were higher in patients with subjective cognitive decline and cognitively impaired patients on the Alzheimer’s continuum compared to healthy controls. Greater depressive symptoms were associated with higher amyloid load in subjective cognitive decline patients, while they were related to higher cognition and glucose metabolism, and to better awareness of cognitive difficulties, in cognitively impaired patients on the Alzheimer’s continuum. In contrast, anxiety symptoms were not associated with brain integrity in any group. Conclusion These data show that more depressive symptoms are associated with greater Alzheimer’s disease biomarkers in subjective cognitive decline patients, while they reflect better cognitive deficit awareness in cognitively impaired patients on the Alzheimer’s continuum. Our findings highlight the relevance of assessing and treating depressive symptoms in the preclinical stages of Alzheimer’s disease.
... The insula is located in the depths of the lateral sulcus, (37) is anatomically related to the frontal, parietal, and temporal lobes (38) and plays vital roles in consciousness, bodily impulses, and in controlling and suppressing natural impulses (39,40). Insular dysfunction has also been linked to diseases including Alzheimer's disease (41) and epilepsy (42). Previous studies have demonstrated abnormal activation of the insula in ON patients (43,44). ...
Article
Full-text available
Objective We used the amplitude of low-frequency fluctuation (ALFF) method to investigate spontaneous brain activity in patients with optic neuritis (ON) in specific frequency bands. Data and Methods A sample of 21 patients with ON (13 female and eight male) and 21 healthy controls (HCs) underwent functional magnetic resonance imaging (fMRI) scans in the resting state. We analyzed the ALFF values at different frequencies (slow-4 band: 0.027–0.073 Hz; slow-5 band: 0.01–0.027 Hz) in ON patients and HCs. Results In the slow-4 frequency range, compared with HCs, ON patients had apparently lower ALFF in the insula and the whack precuneus. In the slow-5 frequency range, ON patients showed significantly increased ALFF in the left parietal inferior and the left postcentral. Conclusion Our results suggest that ON may be involved in abnormal brain function and can provide a basis for clinical research.
... The postcentral gyrus includes primary somatosensory cortex, which has been implicated in processing somatic sensations such as touch, proprioception, and pain, which may be associated with hallucinations, but prior reports associating delusions with right frontal atrophy were not replicated. Depression was associated with cortical thickness in the left superior temporal gyrus, roughly replicative of prior reports of decreased temporal lobe volume (Hayata et al., 2015;Lebedev et al., 2014;Lee et al., 2012). It should be noted that their depression factor was similarly weighted toward depression and apathy and thus may reflect mechanisms underlying both, which may account for differing results from those in the literature. ...
... This is in line with a previous study showing a higher frequency of depressive symptoms in clinical MCI and AD patients compared to controls, while anxiety symptoms were only different between mild and severe AD (Fernández-Martínez et al., 2010). Additionally, we found no association of anxiety symptoms with cognition and neuroimaging data, which is at odds with previous studies showing significant relationships with GM atrophy (Tagai et al., 2014;Hayata et al., 2015) and glucose hypometabolism (Hashimoto et al., 2006) in AD. This might be due to the fact that in the present study we focused on state measures of either anxiety or depressive symptoms, while these previous studies assessed trait anxiety. ...
... Cependant, ces résultats pourraient, au moins partiellement, expliquer que les personnes âgées présentant des symptômes anxieux, soient plus à risque de démence (Fernández-Martínez et al., 2010). Les symptômes anxieux ne sont d'ailleurs associés ni à la cognition, ni à la neuroimagerie dans notre étude, ce qui est contraire aux quelques études précédentes sur le sujet, qui montraient que ces symptômes seraient associés à moins de substance grise (Hayata et al., 2015;Tagai et al., 2014) et de métabolisme du glucose cérébral (Hashimoto et al., 2006) dans cette population. Cependant, ces études ont sélectionné leurs participants selon le syndrome clinique et non selon les critères biologiques, et se sont focalisées sur l'anxiété dite « trait » tandis que nous nous sommes intéressés à l'anxiété « état », qui n'a pas été évaluée dans cette population. ...
Thesis
Les symptômes psychoaffectifs anxieux et dépressifs infra-cliniques sont fréquents chez les personnes âgées et sont associés à un risque accru de développer une démence et de progresser d’un stade prédémentiel à un stade démentiel. Cependant, ils pourraient également être des symptômes associés à une démence, et pourraient constituer une manifestation clinique de la pathologie sous-jacente. L’objectif de cette thèse était de contribuer à une meilleure compréhension des liens entre symptômes anxieux et dépressifs et les modifications cognitives et cérébrales structurales, fonctionnelles et moléculaires typiques de la maladie d’Alzheimer (MA), à la fois dans le vieillissement normal et au cours de cette pathologie. Nos résultats montrent que des symptômes anxieux élevés sont associés à un volume de substance grise plus bas chez les sujets âgés cognitivement sains, et ce uniquement chez les femmes. Cette même association est présente chez les sujets Subjective Cognitive Decline (SCD) recrutés dans la population générale, et montre une vulnérabilité accrue aux maladies neurodégénératives liées à l’âge, telles que les démences. Chez les SCD ayant consulté pour leur déclin cognitif subjectif, des symptômes dépressifs élevés sont associés à une charge amyloïde plus importante dans le cerveau, et donc à un risque accru de développer une MA, tandis que chez les sujets Mild Cognitive Impairment (MCI) et MA amyloïde positifs, ils sont liés à une meilleure cognition et conscience de ses propres troubles. Les symptômes psychoaffectifs semblent donc avoir un rôle évolutif au cours du passage du vieillissement normal au vieillissement pathologique, d’abord manifestation d’une vulnérabilité cérébrale, puis manifestation d’une pathologie sous-jacente et d’un risque de développement de MA, ils sont au contraire un marqueur de préservation chez les patients présentant un déclin cognitif (MCI et MA).
... 30 However, posterior gray matter volume was associated with agitation, 31 and in another study that measured cortical thickness, there was no significant relationship between hyperactivity syndrome and cortical thickness. 32 As such, the results of previous studies on hyperactivity syndrome are so diverse that more research is needed to elucidate the neurobiological mechanism of hyperactivity syndrome in patients with dementia. ...
Article
Full-text available
Objective: Neuropsychiatric symptoms of dementia are prevalent and extremely burdening for the patient and caregivers, but the underlying mechanism of these symptoms has not been investigated. This study aimed to investigate the relationship between neuropsychiatric symptoms and default-mode functional connectivity in Alzheimer's disease. Methods: Neuropsychiatric symptoms were assessed using the Neuropsychiatric Inventory. Functional magnetic resonance imaging was conducted on seventy patients with Alzheimer's disease during rest. We conducted a seed-based functional connectivity analysis to identify anterior and posterior default-mode networks (DMN). Seeds were the medial prefrontal cortex (Montreal Neurological Institute 12, 51, 36; seed radius=3 mm) for the anterior DMN and the precuneus (Montreal Neurological Institute -6, -63, 27; seed radius=3 mm) for the posterior DMN We then correlated the scores on neuropsychiatric inventory syndromes (apathy, hyperactivity, affective, and psychosis syndrome) with maps of connectivity in the default-mode network. Results: There was a significant correlation between decreased connectivity in the medial prefrontal cortex of the anterior defaultmode network and hyperactivity (agitation, irritability, aberrant motor behavior, euphoria, and disinhibition) syndrome (p<0.05, family wise error cluster-level corrected). Conclusion: Our study demonstrated that hyperactivity syndrome is related to hypoconnected default-mode network in Alzheimer's disease. This finding suggests that specific network alterations are associated with certain neuropsychiatric syndromes.
... Although the cognitive impairment was also associated with the insular atrophy, a significant correlation between the insula and depressive symptoms was observed after excluding the effect of the cognitive impairment. The result strongly indicated that the insula is vital in the modulation of emotion, which is consistent with previous research that demonstrated insular structures to be abnormal in patients with depressive disorder (Hayata et al., 2015;Ambrosi et al., 2017;Cooper et al., 2019;Whitton et al., 2019;Xu et al., 2019). The insula, as a vital visceral sensory node, is significantly correlated with somatic symptoms in depressed patients (Zu et al., 2019). ...
Article
Full-text available
Background: Alzheimer’s disease (AD) is characterized by global deterioration in multiple cognitive domains. In addition to cognitive impairment, depressive symptoms are common issues that trouble AD patients. The neuroanatomical basis of depressive symptoms in AD patients has yet to be elucidated. Method: Twenty AD patients and 22 healthy controls (HCs) were recruited for the present study. Depressive symptoms in AD patients and HCs were assessed according to the Hamilton Depression Rating Scale (HDRS). Anatomical structural differences were assessed between AD patients and HCs using voxel-based morphometry (VBM) and surface-based morphometry (SBM). Correlation analyses were conducted to investigate relationships between depressive symptoms and structural altered regions. Multiple pattern analysis using linear support vector machine (SVM) was performed in another independent cohort, which was collected from Alzheimer’s Disease Neuroimaging Initiative (ADNI) data and contained 20 AD patients and 20 HCs, to distinguish AD patients from HCs. Results: Compared with HCs, AD patients exhibited global cerebral atrophy in gray matter volume (GMV) and cortical thickness, including frontal, parietal, temporal, occipital, and insular lobes. In addition, insular GMV was negatively correlated with depressive symptoms. Moreover, SVM-based classification achieved an accuracy of 77.5%, a sensitivity of 70%, and a specificity of 85% by leave-one-out cross-validation. Conclusion: GMV of the insula displayed atrophy among AD patients, which is associated with depressive symptoms. Our observations provide a potential neural substrate for analysis to examine the co-occurrence of AD with depressive symptoms.
... Previous study found predominant behavioral symptoms, have a tendency to affect areas concerned in the salience network, including the anterior insula, the anterior cingulate cortex (ACC), medial orbital prefrontal cortex, thalamus, striatum, and amygdala regions implicated in social and emotional processing, researchers found associations between rapid degeneration in the ACC and reduced cortical thickness in the entorhinal and depression in MCI participants [8]. Symptoms of depression and anxiety were associated with atrophy of insular, right frontal, and temporal cortices [32]. Additionally, hyperactivity disorder was reported with increased connectivity in the salience network (SN) in the right insula and anterior cingulate cortex [32]. ...
... Symptoms of depression and anxiety were associated with atrophy of insular, right frontal, and temporal cortices [32]. Additionally, hyperactivity disorder was reported with increased connectivity in the salience network (SN) in the right insula and anterior cingulate cortex [32]. While insular roles remain completely not understood, there is evidence that the anterior part of the insula, processes emotional experiences. ...
Article
Depression, anxiety and apathy are ‘common neuropsychiatric symptoms (NPS) in Alzheimer’s disease (AD). We aimed to find regional gray matter (GM) volume difference of these symptoms, in AD patients compared to AD control, and investigate possible associations of GM atrophy with cognitive covariant. Study subjects were retrieved from the Alzheimer’s Disease Neuroimaging Initiative database. Thirty-five participants are AD control, 27 AD patients with anxiety, 19 with depression and 24 with apathy, ages ≥ 55.1 years. Recruited subjects had an assessment of their clinical and structural MRI data. GM differences and clinical data were analyzed using voxel-based morphometry and ANOVA with Scheffe post hoc test, respectively. We found significant GM volumes differences in the left insula, left parahippocampal, posterior cingulate and the bilateral putamen in the anxiety group. The results also revealed that the right parahippocampal, Brodmann area 38 and the middle frontal gyrus were significant in patients with depression. Significant results were with a p < 0.05, corrected with AlphaSim program for multiple comparisons. The left insula had a strong negative association with Clinical Dementia Rate Sum of Boxes and Alzheimer’s Disease Assessment Scale-cognitive subscale-13 items in anxiety and apathy groups. The difference in GM density in the left insula and hippocampus plays a crucial role in depression, anxiety and apathy NPS and outline precise approaches to test these symptoms.